Bausch Health Companies | Ventes



Sales Changement Date
Amgen USD 8.15B 936M 2025-03
ANI Pharmaceuticals USD 190.6M 42.3M 2024-12
Aurora Cannabis CAD 88.2M 7.08M 2024-12
Bausch Health Companies USD 2.26B 300M 2025-03
Biogen USD 2.43B 24.7M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Canopy Growth CAD 74.76M 11.77M 2024-12
Corcept Therapeutics USD 157.2M 24.69M 2025-03
Danaher USD 5.74B 800M 2025-03
Drreddys Laboratories INR 83.59B 3.42B 2024-12
Eli Lilly USD 12.73B 802.8M 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
Novo Nordisk 85.68B 14.37B 2024-12
Pacira USD 187.25M 18.68M 2024-12
Perrigo USD 1.14B 50.8M 2024-12
Prestige Brands USD 290.32M 6.53M 2024-12
Supernus Pharmaceuticals USD 174.16M 1.53M 2024-12
Vertex Pharmaceuticals USD 2.77B 142M 2025-03
Zoetis USD 2.32B 71M 2024-12



Bausch Health Companies Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.